CARA - Cara Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts6677
Avg. Estimate-0.51-0.46-1.8-1.02
Low Estimate-0.6-0.62-2.21-1.68
High Estimate-0.44-0.23-1.31-0.6
Year Ago EPS-0.08-0.43-1.59-1.8
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts6677
Avg. Estimate7.65M14.24M49.02M97.9M
Low Estimate6.4M9.3M38.8M70.5M
High Estimate9.5M22M64.1M134.29M
Year Ago Sales23M10.81M41.87M49.02M
Sales Growth (year/est)-66.70%31.70%17.10%99.70%
Earnings History6/29/20229/29/202212/30/20223/30/2023
EPS Est.-0.25-0.42-0.32-0.52
EPS Actual-0.08-0.43-0.56-0.49
Difference0.17-0.01-0.240.03
Surprise %68.00%-2.40%-75.00%5.80%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-0.51-0.46-1.8-1.02
7 Days Ago-0.51-0.46-1.8-1.02
30 Days Ago-0.52-0.41-1.74-0.75
60 Days Ago-0.52-0.41-1.74-0.75
90 Days Ago-0.2-0.11-0.760.17
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3142
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCARAIndustrySector(s)S&P 500
Current Qtr.-537.50%N/AN/AN/A
Next Qtr.-7.00%N/AN/AN/A
Current Year-13.20%N/AN/AN/A
Next Year43.30%N/AN/AN/A
Next 5 Years (per annum)110.70%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A